Carbon Tax Most Efficient in Tackling Climate Change
It is encouraging to see more and more fellow Republicans shed the reflexive skepticism about climate change that has characterized the GOP for years. Now, Republicans need to offer solutions.
Costs of the Green New Deal
With the government reopened (at least for now), Speaker Nancy Pelosi is poised to begin advancing her party’s policy agenda. High on the list will be the loosely-defined Green New Deal, a federal spending program that will cost $2 trillion, $5.7 trillion, or more, and move the electric power sector to complete reliance on renewable energy sources.
The US labor market data is great. What does it mean for this year’s midterms?
Tomorrow, the American public will get a fresh glimpse at the state of the US labor market. The Bureau of Labor Statistics’ (BLS) release of the September employment report, which will be the next-to-last before the upcoming election, will provide voters new insight on job growth and unemployment rates.
Happy Birthday, FDA Tobacco Plan!
Just over a year ago, the Food and Drug Administration (FDA) announced a bold new plan to reduce nicotine in cigarettes to non-addictive levels and encourage the development of non-combustible nicotine products. Key to the FDA’s approach is an acknowledgement of both the continuum of risks associated with various nicotine delivery mechanisms and the opportunity for innovative products to reduce the health risks associated with tobacco consumption
Supreme Court Ruling on Online Sales Tax Sets Level Playing Field
The Supreme Court’s 5-4 ruling in South Dakota v. Wayfair last weekempowers states to establish a level playing field for the taxation of goods sold by in-state and out-of-state sellers. The court overturned two precedents, dating back to 1967 and 1992, that imposed an artificial physical presence rule on state sales tax systems.
What is Behind that Record-Breaking State Unemployment Rate Data?
The Bureau of Labor Statistics recently reported that the US unemployment rate in May 2018 was 3.8%, the lowest since April 2000. During the past 50 years, the US unemployment rate has been this low only 10% of the time.
- FDA Continues to Expedite Biosimilar Development
- Diminishing Returns from the Government’s Drug Negotiation Program
- Would Senate Passage of an ACA Tax Credit Extension Matter?
- MGA Brief Examines State and Federal PBM Mandates
- FDA Moves to Facilitate Biosimilar Development
- How Pharmaceutical Tariffs Will Affect US Health Care Costs
- MGA Releases New Report Quantifying the Economic Impact of Healthcare Distributors
- The Unsung Hero of the OBBBA: Permanent Expensing
- Alex Brill Interviewed by Biosimilars Review & Report
- MGA Releases New White Paper on Medicare Price Negotiations and Drug Competition
